Vimarsana
Biggest News Aggregation in the World

Mark Tuszynski News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Tuszynski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Tuszynski Today - Breaking & Trending Today

Brainstorm's ALS Data Fail to Persuade FDA Advisors, Who Vote Down the Stem Cell Therapy - Vimarsana News

Brainstorm's ALS Data Fail to Persuade FDA Advisors, Who Vote Down the Stem Cell Therapy

NurOwn, Brainstorm Cell Therapeutics’ experimental stem cell therapy for ALS, did not win the backing of an independent panel of FDA advisors. Many advisory committee members said they want to see more data from another clinical trial, the same guidance the FDA has given the biotech for nearly three years.

Woman dies in fire at Three Oaks mobile home - Vimarsana News

Woman dies in fire at Three Oaks mobile home

THREE OAKS — A woman is dead and a man was hospitalized Tuesday after fire consumed their home at Lakewood Estates Manufactured Homes, northwest of Three Oaks.

Researchers to conduct Phase 1 gene therapy trial to treat Alzheimer's disease - Vimarsana News

Researchers to conduct Phase 1 gene therapy trial to treat Alzheimer's disease

The National Institute on Aging (NIA), part of the National Institutes of Health, has awarded a $5 million grant to researchers at University of California San Diego School of Medicine to conduct a first-in-human Phase 1 clinical trial of a gene therapy for treating Alzheimer's disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia.

First Clinical Trial to Assess Alzheimer's Gene Therapy Receives $5 Million - Vimarsana News

First Clinical Trial to Assess Alzheimer's Gene Therapy Receives $5 Million

First Clinical Trial to Assess Alzheimer’s Gene Therapy Receives $5 Million News_release The National Institute on Aging (NIA), part of the National Institutes of Health, has awarded a $5 million grant to researchers at University of California San Diego School of Medicine to conduct a first-in-human Phase 1 clinical trial of a gene therapy for treating Alzheimer’s disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia. Gene therapy is an experimental technique that uses genes or gene products to treat or prevent disease instead of relying ...

Source: ucsd.edu
La Jolla permit reviewers approve two home projects and dispute design plan for addition to historic house - Vimarsana News

La Jolla permit reviewers approve two home projects and dispute design plan for addition to historic house

La Jolla permit reviewers approve two home projects and dispute design plan for addition to historic house La Jolla’s Development Permit Review Committee approved plans to add to this property at 5692 Dolphin Place. (Courtesy) Print Two Bird Rock residential projects got the La Jolla Development Permit Review Committee’s approval on the first try during the board’s March 9 meeting. Any preliminary review can be made final by a unanimous vote, which allows the board to make a recommendation on the project. Such was the case for a proposal to add a 444-square-foot unit to a house...